Watchlist Price Alert

Amgen Inc. (AMGN)

NASDAQ: AMGN · Real-Time Price · USD

288.76

-0.57 (-0.20%)

At close: Jun 23, 2025, 10:23 AM

Amgen Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	11.97B	10.94B	7.63B	7.99B	6.27B	6.04B	6.95B	3.8B	3.24B
Short-Term Investments	n/a	10.94B	1.68B	48M	4.38B	2.87B	22.36B	37.88B	34.84B
Long-Term Investments	n/a	n/a	3.5B	4.51B	4.42B	548M	683M	719M	655M
Other Long-Term Assets	9.93B	8.96B	5.9B	6.52B	5.64B	2.22B	1.7B	2.12B	1.63B
Receivables	7.5B	7.94B	5.56B	4.89B	4.53B	4.06B	3.58B	3.24B	3.17B
Inventory	7B	9.52B	4.93B	4.09B	3.89B	3.58B	2.94B	2.83B	2.75B
Other Current Assets	419M	281M	1.18B	1.14B	923M	949M	1.79B	1.73B	2.02B
Total Current Assets	29.03B	30.33B	22.19B	19.39B	21.14B	18.44B	37.62B	49.48B	46.01B
Property-Plant & Equipment	6.54B	6.59B	5.43B	5.18B	4.89B	4.93B	4.96B	4.99B	4.96B
Goodwill & Intangibles	46.34B	51.27B	31.61B	30.07B	31.28B	34.12B	22.14B	23.37B	25.03B
Total Long-Term Assets	62.81B	66.82B	42.94B	41.78B	41.8B	41.27B	28.8B	30.48B	31.62B
Total Assets	91.84B	97.15B	65.12B	61.16B	62.95B	59.71B	66.42B	79.95B	77.63B
Account Payables	1.91B	1.59B	1.57B	1.37B	1.42B	1.37B	1.21B	1.35B	917M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	3.55B	1.44B	1.59B	87M	91M	2.95B	4.42B	1.15B	4.4B
Other Current Liabilities	1.33B	1.32B	2.33B	2.33B	2.32B	2.07B	1.45B	1.41B	1.29B
Total Current Liabilities	23.1B	18.39B	15.69B	12.18B	11.65B	12.84B	13.49B	9.02B	11.2B
Long-Term Debt	56.55B	63.17B	37.35B	33.22B	32.9B	26.95B	29.51B	34.19B	30.19B
Other Long-Term Liabilities	4.7B	6.32B	7.88B	8.53B	8.69B	9.26B	10.05B	10.34B	3.92B
Total Long-Term Liabilities	62.86B	72.53B	45.77B	42.28B	41.89B	37.2B	40.43B	45.69B	36.55B
Total Liabilities	85.96B	90.92B	61.46B	54.47B	53.54B	50.03B	53.92B	54.71B	47.75B
Total Debt	60.1B	64.61B	38.95B	33.31B	32.99B	29.9B	33.93B	35.34B	34.6B
Common Stock	33.53B	33.07B	32.51B	32.1B	31.8B	31.53B	31.25B	30.99B	30.78B
Retained Earnings	-27.59B	-26.55B	-28.62B	-24.6B	-21.41B	-21.33B	-17.98B	-5.07B	-438M
Comprehensive Income	-66M	-289M	-231M	-796M	-985M	-528M	-769M	-679M	-471M
Shareholders Equity	5.88B	6.23B	3.66B	6.7B	9.41B	9.67B	12.5B	25.24B	29.88B
Total Investments	n/a	10.94B	1.68B	48M	4.38B	2.87B	22.36B	37.88B	34.84B